FluoGuide is trading at SEK 32.80, down 6.8%, extending a sharp multi-day decline from levels around SEK 39.00 earlier in the week.
- The downward trend follows a period of general volatility within the Nordic small-cap biotech sector.
- Investor sentiment continues to be pressured by prior concerns regarding potential dilution and the company's future financing needs.
- No fresh company-specific announcements or analyst actions have been identified to account for the current move on July 15, 2026.